Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Angelini

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
International Journal of Oncology|May 3, 2011
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesisC Gridelli, G Ianniello, G Ambrosini, et al.
Brain : a Journal of Neurology|July 19, 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosisSofia V Abrahamsson, Daniela F Angelini, Amy N Dubinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2015
A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid LeukemiaDaniela F Angelini, Tiziana Ottone, Gisella Guerrera, et al.
La Clinica Terapeutica|July 20, 2022
What hides beneath the scar: sexuality and breast cancer what women don't say: A single-center studyE Gozzi, A R La Manna, L Rossi, et al.
Cell Death and Differentiation|March 16, 2021
Characterization of a natural variant of human NDP52 and its functional consequences on mitophagyAnthea Di Rita, Daniela F Angelini, Teresa Maiorino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group StudyM O Nicoletto, S Tumolo, R Talamini, et al.
Oncotarget|April 22, 2017
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitroNélida I Noguera, Elvira Pelosi, Daniela F Angelini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2010
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory responseDomenico Mattoscio, Virgilio Evangelista, Raimondo De Cristofaro, et al.
Leukemia|September 10, 2025
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemiasAlessandra Zaza, Giuseppe Zardo, Cristina Banella, et al.
Annals of Neurology|June 18, 2026
From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple SclerosisMarta Pirronello, Mario Picozza, Gisella Guerrera, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
International Journal of Oncology|May 3, 2011
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesisC Gridelli, G Ianniello, G Ambrosini, et al.
Brain : a Journal of Neurology|July 19, 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosisSofia V Abrahamsson, Daniela F Angelini, Amy N Dubinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2015
A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid LeukemiaDaniela F Angelini, Tiziana Ottone, Gisella Guerrera, et al.
La Clinica Terapeutica|July 20, 2022
What hides beneath the scar: sexuality and breast cancer what women don't say: A single-center studyE Gozzi, A R La Manna, L Rossi, et al.
Cell Death and Differentiation|March 16, 2021
Characterization of a natural variant of human NDP52 and its functional consequences on mitophagyAnthea Di Rita, Daniela F Angelini, Teresa Maiorino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group StudyM O Nicoletto, S Tumolo, R Talamini, et al.
Oncotarget|April 22, 2017
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitroNélida I Noguera, Elvira Pelosi, Daniela F Angelini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2010
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory responseDomenico Mattoscio, Virgilio Evangelista, Raimondo De Cristofaro, et al.
Leukemia|September 10, 2025
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemiasAlessandra Zaza, Giuseppe Zardo, Cristina Banella, et al.
Annals of Neurology|June 18, 2026
From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple SclerosisMarta Pirronello, Mario Picozza, Gisella Guerrera, et al.
Pageof 16